Stay updated on Long-term Safety of Dupilumab in Pediatric AD Clinical Trial

Sign up to get notified when there's something new on the Long-term Safety of Dupilumab in Pediatric AD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Long-term Safety of Dupilumab in Pediatric AD Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov study page continues to display a 403 Forbidden error. The footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T12:56:24.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-12T14:17:48.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is now displayed, replacing the study content with an access-denied message. The header and footer suggest a site-wide access restriction rather than study information.
    Difference
    19%
    Check dated 2026-09-21T20:19:15.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5. This indicates a minor software/documentation version update rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-08-31T18:29:03.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    A funding disclosure line reading '2015 ( U.S. NIH Grant/Contract )' was added, providing attribution for NIH support within the study's documentation. The addition clarifies the source of funding associated with the U.S. portion of the trial.
    Difference
    0.0%
    Check dated 2026-08-24T20:07:03.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The page's revision was updated to v3.6.5 and the previous v3.6.4 was removed, reflecting a small metadata update to the revision history.
    Difference
    0.0%
    Check dated 2026-08-10T14:41:33.000Z thumbnail image

Stay in the know with updates to Long-term Safety of Dupilumab in Pediatric AD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Long-term Safety of Dupilumab in Pediatric AD Clinical Trial page.